These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11952341)
1. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341 [TBL] [Abstract][Full Text] [Related]
2. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356 [TBL] [Abstract][Full Text] [Related]
3. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Carmella SG; Borukhova A; Akerkar SA; Hecht SS Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369 [TBL] [Abstract][Full Text] [Related]
5. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Carmella SG; Akerkar SA; Richie JP; Hecht SS Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830 [TBL] [Abstract][Full Text] [Related]
6. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine. Carmella SG; Ye M; Upadhyaya P; Hecht SS Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969 [TBL] [Abstract][Full Text] [Related]
7. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Murphy SE; Carmella SG; Idris AM; Hoffmann D Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210 [TBL] [Abstract][Full Text] [Related]
8. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers. Chen G; Luo S; Kozlovich S; Lazarus P Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298 [TBL] [Abstract][Full Text] [Related]
9. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL. Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206 [TBL] [Abstract][Full Text] [Related]
10. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4. Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623 [TBL] [Abstract][Full Text] [Related]
11. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205 [TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse. Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810 [TBL] [Abstract][Full Text] [Related]
13. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Carmella SG; Han S; Fristad A; Yang Y; Hecht SS Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291 [TBL] [Abstract][Full Text] [Related]
14. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760 [TBL] [Abstract][Full Text] [Related]
15. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Hecht SS; Chung FL; Richie JP; Akerkar SA; Borukhova A; Skowronski L; Carmella SG Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):877-84. PubMed ID: 8634661 [TBL] [Abstract][Full Text] [Related]
16. Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines. Upadhyaya P; McIntee EJ; Hecht SS Chem Res Toxicol; 2001 May; 14(5):555-61. PubMed ID: 11368554 [TBL] [Abstract][Full Text] [Related]
17. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261 [TBL] [Abstract][Full Text] [Related]
18. Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry. Yao L; Zheng S; Guan Y; Yang J; Liu B; Wang W; Zhu X Anal Chim Acta; 2013 Jul; 788():61-7. PubMed ID: 23845482 [TBL] [Abstract][Full Text] [Related]
19. One-Week Kava Dietary Supplementation Increases Both Urinary Hu Q; Tang Z; Lynch A; Freeman B; Fujioka N; Salloum RG; Malaty J; Orlando FA; Langaee T; Huo Z; Xing C Chem Res Toxicol; 2024 Sep; 37(9):1515-1523. PubMed ID: 39001862 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]